Innovative Softgel Formula Offers Support for Dry Eyes
11.07.18
Catalent and Anklam Extrakt partner to develop combination of maqui berry extract and omega-3 fish oil.
Booth 2233
Catalent Pharma Solutions, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has partnered with Anklam Extrakt GmbH, to develop an innovative softgel formula for people suffering from dry eye discomfort. The product will be launched SupplySide West Booth 2233.
Anklam Extrakt’s new product, OPTIBRIGHT Softgel, combines its unique blend of 30 mg MaquiBright maqui berry extract and 450 mg of omega-3 fish oil, with Catalent’s softgel formulation and encapsulation technology. The result is a convenient, once-or-twice daily supplement intended to aid tear formation and provide relief for dry eye discomfort.
At SupplySide West, Catalent and Anklam Extrakt will host an expert speaking session at 11 am on Thursday, Nov. 8 at the Exhibition Theatre Booth 1381, titled “Latest Advancements in Nutritional Supplements for Dry Eyes.” The presentation, by Dr. Andrew Myers, scientific advisor, nutritional softgels, Catalent Pharma Solutions, will discuss the advantages this product, with its unique formulation of active ingredients, brings to the marketplace.
Timothy Doran, Catalent’s vice president and general manager of nutritional softgels commented, “At Catalent, we are dedicated to partnering with our customers at every level, to focus on supporting consumers’ needs for health and wellness throughout life.”
Catalent Pharma Solutions, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has partnered with Anklam Extrakt GmbH, to develop an innovative softgel formula for people suffering from dry eye discomfort. The product will be launched SupplySide West Booth 2233.
Anklam Extrakt’s new product, OPTIBRIGHT Softgel, combines its unique blend of 30 mg MaquiBright maqui berry extract and 450 mg of omega-3 fish oil, with Catalent’s softgel formulation and encapsulation technology. The result is a convenient, once-or-twice daily supplement intended to aid tear formation and provide relief for dry eye discomfort.
At SupplySide West, Catalent and Anklam Extrakt will host an expert speaking session at 11 am on Thursday, Nov. 8 at the Exhibition Theatre Booth 1381, titled “Latest Advancements in Nutritional Supplements for Dry Eyes.” The presentation, by Dr. Andrew Myers, scientific advisor, nutritional softgels, Catalent Pharma Solutions, will discuss the advantages this product, with its unique formulation of active ingredients, brings to the marketplace.
Timothy Doran, Catalent’s vice president and general manager of nutritional softgels commented, “At Catalent, we are dedicated to partnering with our customers at every level, to focus on supporting consumers’ needs for health and wellness throughout life.”
